These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6760660)

  • 1. One-month crossover trial comparing the intraocular pressure control of 3.4% Piloplex twice daily with 2.0% pilocarpine four times daily.
    Duzman E; Quinn CA; Warman A; Warman R
    Acta Ophthalmol (Copenh); 1982 Aug; 60(4):613-21. PubMed ID: 6760660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piloplex, a new long-acting pilocarpine polymer salt. A: Long-term study.
    Ticho U; Blementhal M; Zonis S; Gal A; Blank I; Mazor ZW
    Br J Ophthalmol; 1979 Jan; 63(1):45-7. PubMed ID: 570057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
    Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
    Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy of various metipranolol-pilocarpine combinations in patients with ocular hypertension and primary open-angle glaucoma.
    Sharir M; Zimmerman TJ; del Negro RG; Ball SF; Kooner KS
    J Ocul Pharmacol; 1994; 10(2):411-20. PubMed ID: 7916025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-response study of piloplex for duration of action.
    Klein HZ; Lugo M; Shields MB; Leon J; Duzman E
    Am J Ophthalmol; 1985 Jan; 99(1):23-6. PubMed ID: 3838120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
    Andermann C; Mialhe D; Arne JL; Vende D; Bec P
    J Fr Ophtalmol; 1983; 6(4):367-74. PubMed ID: 6350412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study.
    Høvding G; Aasved H
    Acta Ophthalmol (Copenh); 1987 Oct; 65(5):594-601. PubMed ID: 3321877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piloplex, a new long-acting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and Piloplex eye drops.
    Mazor Z; Ticho U; Rehany U; Rose L
    Br J Ophthalmol; 1979 Jan; 63(1):48-51. PubMed ID: 367431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial with Piloplex--a new long-acting pilocarpine compound: preliminary report.
    Ticho U; Blumenthal M; Zonis S; Gal A; Blank I; Mazor ZW
    Ann Ophthalmol; 1979 Apr; 11(4):555-61. PubMed ID: 572195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
    Zadok D; Geyer O; Zadok J; Lazar M; Krakowski D; Nemet P
    Am J Ophthalmol; 1994 Jun; 117(6):728-31. PubMed ID: 8198156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K; Snyder E; Adamsons I
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma].
    Yie T; Liang L; Chen X
    Yan Ke Xue Bao; 2000 Jun; 16(2):77-80. PubMed ID: 12579908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
    Robin AL
    Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
    Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
    Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.
    Berlin MS; Rowe-Rendleman C; Ahmed I; Ross DT; Fujii A; Ouchi T; Quach C; Wood A; Ward CL
    Br J Ophthalmol; 2016 Jun; 100(6):843-7. PubMed ID: 26453641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.